<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-130202</identifier>
<setSpec>1888-4008</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Antibiotic resistance of Neisseria gonorrhoeae in the Camp de Tarragona Health Region catchment area</dc:title>
<dc:description xml:lang="en">Introduction. The ability of Neisseria gonorrhoeae to develop resistance mechanisms needs a constant assesment of the efficacy of the available treatments. Methods. A retrospective study was conducted on strains isolated in the Health Region of Camp de Tarragona between 2004 and 2013. Results. The rate of resistance to ciprofloxacin was about 48.2%. No ceftriaxone or spectinomycin resistant strain was isolated. Conclusion. In our area, ceftriaxone is the best therapeutic option in the treatment of uncomplicated gonorrhea (AU)</dc:description>
<dc:creator>Gómez, Frederic</dc:creator>
<dc:creator>Pujol, Isabel</dc:creator>
<dc:creator>Simó, Josep Maria</dc:creator>
<dc:creator>Puerta, María José</dc:creator>
<dc:creator>Camps, Jordi</dc:creator>
<dc:creator>Villuendas, Óscar</dc:creator>
<dc:creator>Ballester, Frederic</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. La capacidad de Neisseria gonorrhoeae para desarrollar mecanismos de resistencia hace necesaria una evaluación constante de la eficacia de los tratamientos disponibles. Métodos. Estudio retrospectivo de las cepas aisladas en la Región Sanitaria del Camp de Tarragona entre 2004 y 2013. Resultados. La tasa de resistencia a ciprofloxacino fue del 48,2%. No se aisló ninguna cepa resistente a ceftriaxona ni espectinomicina. Conclusión. En nuestra área, ceftriaxona constituye la mejor opción terapéutica en el tratamiento de la infección gonocócica no complicada (AU)</dc:description>
<dc:source>Rev. lab. clín;7(4): 145-148, oct.-dic. 2014. tab, ilus</dc:source>
<dc:identifier>ibc-130202</dc:identifier>
<dc:title xml:lang="es">Resistencia antibiótica de Neisseria gonorrhoeae en el área de influencia de la Región Sanitaria del Camp de Tarragona</dc:title>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d22164^s22021</dc:subject>
<dc:subject>^d8759^s22057</dc:subject>
<dc:subject>^d23036^s22021</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d8759^s22016</dc:subject>
<dc:subject>^d22165</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d19603</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d9536^s22052</dc:subject>
<dc:subject>^d9536^s22021</dc:subject>
<dc:subject>^d22254^s22021</dc:subject>
<dc:subject>^d9537^s22001</dc:subject>
<dc:subject>^d9536^s22001</dc:subject>
<dc:subject>^d9537^s22021</dc:subject>
<dc:subject>^d911^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201412</dc:date>
</metadata>
</record>
</ibecs-document>
